Vishal Deshmukh is a Principal at Foresite Capital, focusing on biotech investments. He previously led discovery biology at Kinnate Biopharma and Biosplice Therapeutics, and holds a PhD from Scripps Research.
At firms with a similar stage, sector and check size.



One email when Vishal's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckVishal Deshmukh is a Principal at Foresite Capital, focusing on biotech investments. He previously led discovery biology at Kinnate Biopharma and Biosplice Therapeutics, and holds a PhD from Scripps Research.
Foresite Capital has not reported a check size. It invests at pre-seed, seed, series a, series b.
A warm intro from a founder Foresite Capital backed works best.
Visiting Scientist at California Institute for Biomedical Research (Calibr); Visiting Scientist at Genomics Institute of the Novartis Research Foundation (GNF); Director of Biology at Biosplice Therapeutics; Director of Discovery Biology at Kinnate Biopharma.
Last updated 2026-10-15. Is this you? Ask for a correction.